Key terms
About CGEN
Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses on research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest CGEN news
Mar 08
7:20am ET
Analysts Offer Insights on Healthcare Companies: Cigna (CI), Compugen (CGEN) and OrthoPediatrics (KIDS)
Mar 07
10:29am ET
Biotech Alert: Searches spiking for these stocks today
Mar 06
11:18pm ET
Buy Rating Justified by Compugen’s Positive Clinical Outlook and Financial Stability
Mar 05
7:03am ET
Compugen reports Q4 EPS 11c, consensus 22c
Feb 15
7:11am ET
Compugen names Michelle Mahler M.D. as Chief Medical Officer
Jan 08
7:16am ET
Compugen to receive $10M milestone payment from AstraZeneca
Dec 22
11:14am ET
Biotech Alert: Searches spiking for these stocks today
Dec 21
9:30pm ET
Wall Street Analysts Are Bullish on Top Healthcare Picks
Dec 21
9:05pm ET
Compugen (CGEN) Receives a Buy from Stifel Nicolaus
Dec 21
10:52am ET
Biotech Alert: Searches spiking for these stocks today
Dec 21
1:26am ET
Compugen’s Strategic Partnership with Gilead Bolsters Financial Position and Promises Growth
Dec 19
3:52pm ET
Compugen spikes after deal with Gilead for anti-tumor drug
Dec 19
3:48pm ET
Compugen spikes 180% on $848M deal with Gilead for anti-tumor drug
Dec 19
7:13am ET
Compugen eligible to receive $10M payment upon dosing of AstraZeneca trial
Dec 19
7:06am ET
Gilead and Compugen in license deal for novel pre-clinical immunotherapy program
No recent news articles are available for CGEN
No recent press releases are available for CGEN
CGEN Financials
Key terms
Ad Feedback
CGEN Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
CGEN Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range